2021/04/16 ALA-1000 Receive notice of allowance for patent registration from Korean Intellectual Property Office (Application No. 10-2019-7009185). Post author:alarpharm Post published:21 . 4 . 2021 Post category:Media releases You Might Also Like 2021/08/03 ALA-1000 Receive notice of patent allowance from Japan Patent Office (JPO), Application No. 特願2019-535434. 9 . 8 . 2021 2023/08/02 ALA-3000 has received an Intention to Grant (IGRA) from European Patent Office (EPO) after examination. (Patent Application No. 20739053.5) 10 . 8 . 2023 2022/01/13 Alar Announces Significant Progress on Developing Long-acting Buprenorphine Injectable ALA-1000 14 . 1 . 2022 2023/08/21 ALA-3000 has received the Notice of Eligibility of Grant from Intellectual Property Office of Singapore (IPOS) after the examination.(Patent Application No. 11202104792S) 23 . 8 . 2023 2023/10/12 Receives the notice of exercising the Option in the license agreement of ALA-1000 and related products from INDIVIOR UK LIMITED 12 . 10 . 2023
2021/08/03 ALA-1000 Receive notice of patent allowance from Japan Patent Office (JPO), Application No. 特願2019-535434. 9 . 8 . 2021
2023/08/02 ALA-3000 has received an Intention to Grant (IGRA) from European Patent Office (EPO) after examination. (Patent Application No. 20739053.5) 10 . 8 . 2023
2022/01/13 Alar Announces Significant Progress on Developing Long-acting Buprenorphine Injectable ALA-1000 14 . 1 . 2022
2023/08/21 ALA-3000 has received the Notice of Eligibility of Grant from Intellectual Property Office of Singapore (IPOS) after the examination.(Patent Application No. 11202104792S) 23 . 8 . 2023
2023/10/12 Receives the notice of exercising the Option in the license agreement of ALA-1000 and related products from INDIVIOR UK LIMITED 12 . 10 . 2023
